Simulated tissue structure for surgical training

Information

  • Patent Grant
  • 11158212
  • Patent Number
    11,158,212
  • Date Filed
    Friday, November 13, 2015
    9 years ago
  • Date Issued
    Tuesday, October 26, 2021
    3 years ago
Abstract
A simulated tissue structure for practicing surgical techniques is provided. In particular, a realistic organ model or tissue portion for practicing the removal of a tumor or other undesired tissue followed by suturing a remnant defect as part of the same surgical procedure is provided. The simulated tissue structure includes an artificial tumor disposed between layers of elastomeric material and mounted on a simulated organ wall or tissue portion. The simulated tissue structure is modular and interchangeable. At least one of the layers includes a mesh reinforcement. A defect comprising two juxtapositioned surfaces defining a gap between the surfaces is created in the simulated tissue structure and the trainee practices tumor removal and closure of the gap by suturing in a laparoscopic environment.
Description
FIELD

This application is generally related to surgical training tools, and in particular, to anatomical models simulating organs or tissue for teaching and practicing various surgical techniques and procedures.


BACKGROUND

Medical students as well as experienced doctors learning new surgical techniques must undergo extensive training before they are qualified to perform surgery on human patients. The training must teach proper techniques employing various medical devices for cutting, penetrating, clamping, grasping, stapling and suturing a variety of tissue types. The range of possibilities that a trainee may encounter is great. For example, different organs and patient anatomies and diseases are presented. The thickness and consistency of the various tissue layers will also vary from one part of the body to the next and from one patient to another. Accordingly, the skills required of the techniques and instruments will also vary. Furthermore, the trainee must practice techniques in readily accessible open surgical locations and in locations accessed laparoscopically.


Numerous teaching aids, trainers, simulators and model organs are available for one or more aspects of surgical training. However, there is a need for model organs or simulated tissue elements that are likely to be encountered in endoscopic, laparoscopic, transanal, minimally invasive or other surgical procedures that include the removal of tumors or other tissue structures. In particular, there is a need for realistic model organs for the repeatable practice of removing a tumor or other undesired tissue followed by the closure of the target area by suturing or stapling as part of the same surgical procedure. In view of the above, it is an object of this invention to provide a surgical training device that realistically simulates such particular circumstances encountered during surgery.


SUMMARY

According to one aspect of the invention, a simulated tissue structure for surgical training is provided. The structure includes a defect layer located above the base layer. The defect layer includes at least one defect having two opposed surfaces that define at least one gap between the surfaces. A simulated tumor is located above the defect layer in such a way to overlay at least a portion of the defect. A cover layer is located above the base layer and overlays the tumor.


According to another aspect of the invention, a simulated tissue structure for surgical training is provided. The simulated tissue structure includes at least one simulated tissue module comprising a simulated tissue portion. The structure includes a module support having a first surface opposite from a second surface and defining a thickness therebetween. The module support includes at least one module receiving portion sized and configured to receive and connect with the at least one simulated tissue module. The simulated tissue module is insertable into and removable from the at least one module receiving portion and interchangeable with another simulated tissue module.


According to another aspect of the invention a method for surgical training is provided. The method includes the step of providing a simulated tissue structure comprising an artificial tumor located between a base layer and a cover layer. The base layer and the cover layer are made of elastomeric polymer that may include mesh reinforcement. The simulated tissue structure is placed inside a simulated body cavity of a surgical training device such that the simulated tissue structure is at least partially obscured from view by a user. The user removes the artificial tumor from the simulated tissue structure with instruments passed into the simulated body cavity with the simulated tissue structure obscured from the user and visualized on a video monitor providing a live feed of the simulated tissue structure inside the cavity via a laparoscope or endoscope. At least one defect is created substantially in the location of the tumor. The defect comprises two adjacent surfaces defining a gap. The gap is closed by bringing the two adjacent surfaces together with instruments such as sutures, staples, adhesive or other surgical means. Suturing the gap to bring the two adjacent surfaces together. In one variation, creating a defect includes providing a defect layer in the simulated tissue structure. Providing a defect layer includes providing a defect layer with a pre-formed defect or gap and placing the defect layer such that the defect layer is between the base layer and the cover layer and at least a portion of the defect is located underneath the artificial tumor. In another variation, creating a defect includes cutting at least one of the base layer and cover layer. Removing the artificial tumor from the simulated tissue structure includes removing the artificial tumor through the defect created by cutting.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a side view of a surgical training device with a model organ according to the present invention.



FIG. 2A illustrates a side cross-sectional view of a simulated tissue structure according to the present invention.



FIG. 2B illustrates a side cross-sectional view of a simulated tissue structure with tumor excised according to the present invention.



FIG. 2C illustrates a side cross-sectional view of a simulated tissue structure with an open suture according to the present invention.



FIG. 2D illustrates a side cross-sectional view of a simulated tissue structure with a closed suture according to the present invention.



FIG. 3A illustrates a top view of a defect layer having a circular shaped defect according to the present invention.



FIG. 3B illustrates a top view of a defect layer having an elongated defect according to the present invention.



FIG. 3C illustrates a top view of a defect layer having an amorphous defect according to the present invention.



FIG. 3D illustrates a top view of a defect layer having a two-piece defect according to the present invention.



FIG. 3E illustrates a top view of a multi-part defect layer according to the present invention.



FIG. 3F illustrates a top view of a defect layer having multiple defects according to the present invention.



FIG. 4 illustrates a top view of a simulated tissue structure according to the present invention.



FIG. 5 illustrates a side cross-sectional view of a simulated tissue structure according to the present invention.



FIG. 6A illustrates a perspective view of a modular tissue structure and support according to the present invention.



FIG. 6B illustrates a perspective view of a modular tissue structure and support according to the present invention.



FIG. 7 illustrates a cross-sectional view of a simulated tissue structure configured to mimic a human uterus according to the present invention.



FIG. 8 illustrates a top view of a modular tissue structure according to the present invention.



FIG. 9 illustrates a side view of a modular tissue structure according to the present invention.



FIG. 10A illustrates a perspective view of a simulated tissue structure according to the present invention.



FIG. 10B illustrates a perspective view of a simulated tissue structure according to the present invention.



FIG. 11A illustrates a perspective view of a simulated tissue structure according to the present invention.



FIG. 11B illustrates a perspective view of a simulated tissue structure according to the present invention.



FIG. 12 illustrates a perspective view of a suture needle and a simulated tissue structure according to the present invention.





DETAILED DESCRIPTION

A surgical training device 10 that is configured to mimic the torso of a patient such as the abdominal region is shown in FIG. 1. The surgical training device 10 provides a simulated body cavity 18 substantially obscured from the user for receiving model organs or simulated or live tissue 20. The body cavity 18 is accessed via a tissue simulation region 19 that is penetrated by the user employing devices to practice surgical techniques on the tissue or organ 20 found located in the body cavity 18. Although the body cavity 18 is shown to be accessible through a tissue simulation region 19, a hand-assisted access device or single-site port device may be alternatively employed to access the body cavity 18 as described in U.S. patent application Ser. No. 13/248,449 entitled “Portable Laparoscopic Trainer” filed on Sep. 29, 2011 and incorporated herein by reference in its entirety. The surgical training device 10 is particularly well suited for practicing laparoscopic or other minimally invasive surgical procedures.


The surgical training device 10 includes a base 12 and a top cover 14 connected to and spaced apart from the base 12 to define an internal body cavity 18 between the top cover 14 and the base 12. At least one leg 16 interconnects and spaces apart the top cover 14 and base 12. A model organ or simulated tissue 20 is disposed within the body cavity 18. The model organ 20 shown in FIG. 1 is a partial colon or intestine that is shown suspended from the top cover 14 by tethers 22 and connected to at least one leg 24. The at least one leg 24 has an aperture (not shown) facing the internal body cavity 18. The model colon 20 includes a tube 26 having a proximal end and a distal end. The proximal end of the tube 26 is interconnected with the aperture of the leg 16 such that the aperture provides an access port to the lumen of the tube 26. The access port and aperture is shown to be closed off in FIG. 1 with an access device 28 which in combination with a sealed distal end of the tube 26 provides a model organ 20 that is adapted for insufflation with fluid deliverable via an insufflation port 30. An optional insert 32 made of soft material such as silicone creates a realistic interface for the access port. The distal end of the tube 26 extends into the body cavity 18 and is suspended within the body cavity 18. The interior of the tube 26 of the simulated organ 20 is accessible via the access port of leg 24 or via the tissue simulation region 19 or instrument insertion ports 34. An endoscopic camera inserted into the body cavity 18 or into the organ 20 via the access port generates a live image for display on a fold out video screen 36 shown in the closed position in FIG. 1. Although the simulated organ 20 of FIG. 1 is ideal for practicing procedures related to transanal minimally invasive surgery, any simulated organ or tissue portion may be employed. One particular aspect of the organ 20 is at least one tumor or defect 38 is provided and connected to the organ. As shown in FIG. 1, the tumor 38 is connected to the wall of the organ tube 26.


Turning now to FIG. 2A there is shown a partial side cross-sectional view of a portion of a simulated organ 20 that includes the tumor 38. The simulated organ or tissue 20 includes a base layer or organ wall 40. The organ wall 40 is made from a material configured to mimic real live tissue such as silicone or other polymer and is dyed appropriately. One or more base layers 40 of varying thicknesses and colorations may be employed to comprise the entirety of the wall 40. In one variation, the organ wall 40 is rigid and made of polymeric material. Above the base layer 40 is a second layer or defect layer 42. The defect layer 42 is the same size or smaller than the base layer 40 forming a raised platform for the tumor 38. The defect layer 42 is connected to the base layer 40 by adhesive or other means known to one having ordinary skill in the art including being integrally formed with the base layer 40 as a single unit. The defect layer 42 is made of silicone and in one variation of the same color as the base layer 40 such that the defect layer 42 blends into the background of the base layer 40. The defect layer 42 includes at least one defect or gap 44. In one variation, the defect 44 is a pre-fabricated breach in the defect layer 42 that mimics an incision, gap or other void in real tissue resulting from a tear, cut, removal or other surgical procedure that requires surgical attention by way of suturing, stapling or the like to close the defect. Such a situation arises most often in the removal of a tumor 38 where surrounding tissue is also removed together with the tumor 38 to preventatively ensure the entirety of the tumor is excised leaving behind a remnant defect in the tissue. The defect 44 comprises two opposed sides or surfaces defining a gap therebetween. Although the adjacent sides or surfaces are shown to be vertical with respect to the base layer 40, the invention is not so limited and the juxtaposed surfaces or sides can have any shape and, for example, be curved. The defect 44 can be any shape as will be discussed with respect to FIGS. 3A-3F.


Turning now to FIG. 3A, there is shown a top view of a defect layer 42 having a circular defect 44. A defect layer 42 with an elongated, oblong or elliptically shaped defect 44 is shown in the FIG. 3B. The defect 44 can be amorphic or any shape as shown in FIG. 3C. The defect layer 42 may be multi-part as shown in FIG. 3D wherein the defect layer 42 includes two or more adjacent defect layer pieces 42a, 42b juxtaposed to create at least one defect 44 therebetween. Another multi-part defect layer 42 is shown in FIG. 3E where a plurality of adjacent defect layer pieces 42a, 42b and 42c form one or more defects 44 therebetween. Of course, a defect layer 42 may include multiple defects 44a, 44b and 44c as shown in FIG. 3F. The defects 44 may all be the same or have different shapes as shown in FIG. 3F. The shape, thickness and size of the defect allow the surgeon trainee to practice suturing across defects of varying difficulty. In one variation, the defect layer 42 is not of equal thickness. Instead, the thickness of the defect layer 42 varies at the defect 44 location to increase the difficulty of suturing or closing the defect.


Referring back to FIG. 2A, a tumor 38 is located above the defect layer 42. The tumor 38 is preferably a different color from the base layer 40 or defect layer 42 or both such that it is readily identifiable by the trainee. Preferably, the tumor 38 is made of silicone or other polymer material and is red, black, blue or dark brown in color. In general, the tumor 38 is of a darker color than the base or defect layers 40, 42 or otherwise in contrast therewith when viewed through a scope. In one variation, the tumor 38 is connected to the defect layer 42 by adhesive or other means known to one of ordinary skill in the art. In another variation, the tumor 38 is not connected or attached to the defect layer 42 but is removably located thereon.


Still referencing FIG. 2A, the simulated tissue structure 20 includes a cover layer 46 located above the tumor 38. In one variation, the cover layer 46 overlays the tumor 38, defect layer 42 and the base layer 40. The cover layer 46 is preferably transparent or translucent in color and made of a polymer material such as silicone. In another variation, the cover layer 46 is the same color as the base layer 40 or defect layer 42. The cover layer 46 is at least as thick as the base layer 40 or defect layer 42 and in one variation is thinner than the defect layer 42 and in another variation is thinner than the base layer 40. The cover layer 46 is sized to cover the entire tumor 38 and defect layer 42 and is big enough to contact the base layer 40 in one variation. In another variation, the cover layer 46 is sized to cover the entire tumor 38 and contact the defect layer 40. The cover layer 46 is connected to the base layer 40, defect layer 42, tumor 38 or any more than one of the three layers by way of adhesive or other means known to one of ordinary skill in the art. In another variation, the cover layer 46 is smaller and connected to the defect layer 42 alone. In yet another variation, the cover layer 46 is connected to both the defect layer 42 and base layer 42 by adhesive or other means known to one of ordinary skill in the art. The cover layer 46 can be any shape or sized and be configured to provide a smooth surface to the surgeon instead of a layered surface to the artificial tumor location. The cover layer 46, tumor 38, defect layer 42 or base layer 40 includes surface texturing in one variation. Also, the cover layer 46 assists in keeping the tumor 38 and defect layer 42 sandwiched between the cover layer 46 and base layer 40 which is advantageous in a variation wherein the tumor 38 is not adhered to the defect layer 42. A top planar view of the base layer 40, defect layer 42, cover layer 46 and tumor 38 is shown in FIG. 4. In one variation, any one or more of the base layer 40, defect layer 42 and cover layer 46 is formed of silicone molded over a woven, fabric, or mesh material such as nylon or cheesecloth so that the silicone layer has an integrated mesh structural support or other type of reinforcement. Any one or more of the layers 38, 40, 42, 46 can include a fabric or mesh reinforcement combined with an elastic polymer such silicone. The mesh support aids in preventing the suture, staple, or suture needle from tearing through at least one of layers and especially the defect layer 42 when the suture is pulled to close the gap 44.


In FIG. 2B, the tumor 38 and a portion of the cover layer 46 are shown excised from the base layer 40. The excision is performed by the trainee using a surgical instrument such as a scalpel or other medical instrument to remove the tumor 38. The trainee will cut through the cover layer 46 around the tumor 38, isolate the tumor 38, lift and remove the tumor 38 away from the site to expose the underlying defect 44 as shown in FIG. 2B. Then, as shown in FIG. 2C the trainee sutures the defect 44 using a surgical suture 48 bringing the lips or edges of the defect layer 42 together as shown in FIG. 2D, thereby, practicing the closing of a gap or wound created by the surgical removal of a tumor 38. Cutting the at least one layer to create an opening and removing the artificial tumor and suturing the gap is performed while the simulated tissue structure is disposed inside a simulated body cavity 18 of a surgical training device such that the simulated tissue structure is at least partially obscured from view by the user.


Turning now to FIG. 5, there is shown another variation in which there is no pre-formed gap or defect in the second or defect layer 42. Instead, upon excising the tumor 38, the defect is created by the user in one or more of the cover layer 46, defect layer 42, base layer 40 and any remaining tumor portion not removed by the user. The user would then practice suturing the created defect in any of these layers 38, 40, 42, 46. In one such variation, one of the defect layer 42 or base layer 40 is omitted from the construct. In another variation, the tumor 38 is located on a base layer 40 and the defect layer 42 is placed over the tumor 38 such that the defect layer 42 is above the tumor 38. In such a variation, a cover layer 46 may or may not be included. If a cover layer 46 is included it may be integrally formed together with the defect layer as a separate unitary layer. In any of the constructs described above with respect to FIGS. 2-5, the constructs may be flipped upside down or otherwise the layers placed in reverse or otherwise the construct being approachable by the user from either the top or bottom direction with the thicknesses and colors of the layers being adjusted accordingly if necessary to provide the simulated effects of real tissue.


Turning now to FIGS. 6A and 6B, in any of the variations in this description, the simulated tissue construct can be modular such that it is not integrally formed with the entire simulated organ 20 but instead configured as a module 50 that is removable and interchangeable. One or more modules 50 are supported or contained in a module support 52. A module support 52 includes a first surface 51, a second surface 53 and one or more tumor module receiving portions 54, 56, 58 formed in the support 52. The tumor support 52 can be rigid or pliable and made of polymeric material. The tumor support 52 may also comprise a sheet of elastomeric material. The module receiving portions 54, 56, 58 are each sized and configured to receive a correspondingly sized and configured module 50. The modules 50 and module receiving portions 54, 56, 48 in FIG. 6 are shown to be circular; however, the tumor module 50 can be any shape with a complementary shaped receiving portion formed in the module support 52. The thickness of the support 52 can vary providing the construct with varying depths of tumor module 50 positioning. The module receiving portions 54, 56, 58 may include bottom walls onto which the tumor modules 50 may rest. Alternatively, the tumor receiving portions 54, 56, 58 extend between openings in the first surface 51 and the second surface 53 with the modules 50 with tumor 38 being connected between or at one of the openings at either surface 51, 53 or suspended within the tumor receiving portion. For this purpose, the tumor modules 50 and module receiving portions 54, 56, 58 are configured with connecting features to provide a snap-fit engagement, hook-and-loop engagement, friction fit engagement, or the like for placing the tumor modules 50 at any location within the module receiving portions 54, 56, 58 of the module support 52. In one variation, a single tumor module 50 includes one or more tumors 38. The module support 52 is loaded with one or more tumor modules 50 and the simulated tissue construct 20 is inserted into the body cavity 18 of the surgical training device 10, framework or other torso model. It can be placed on the base 12 of the training device 10 or suspended within the body cavity 18 of the training device 10. The simulated tissue construct 20 and/or training device is fashioned with attachment mechanisms such as clips, fasteners, wires, hook-and-loop type fasteners and the like for placement, suspension or connection of the simulated tissue construct 20 to a training device 10.


With particular reference to FIG. 6B, there is shown a module support 52 that includes more than one layer. The module support 52 of FIG. 6B includes a first layer 57 connected to a second layer 55. In one variation, the first layer 57 is made of a sheet of elastomeric material and the second layer 55 is made of any suitable polymeric material such as low-density elastomeric foam. The second layer 55 serves as a support for the first layer 57. The second layer 55 also advantageously provides depth to the module support 52 permitting the tumors 38 within the modules 50 to be placed deeply into the module support 52 relative to the first surface 51. Module receiving portions 54, 56, 58 are formed in one or more than one of the first layer 57 and the second layer 55. Module receiving portions 54, 56, 58 formed in the second layer 55 may have a different shape than the shape the same module receiving portion 54, 56, 58 has in the first layer 57. In one variation, the tumor module 50 comprises at least only the simulated tumor 38 which is embedded or buried inside the second layer 55 with at least one of the first layer 57 or second layer 55 constituting a defect layer which the user can practice closing. As an alternative, the first layer 57 does not include a module receiving portion but instead the first layer 57 serves as a cover layer which the user practices cutting through to access the tumor 38 located in a tumor receiving portion formed in the second layer 55. In such variation, the first layer 57 can be a sheet of elastomeric material such as silicone and the second layer 55 is a layer of low-density elastomeric foam. The module support 52 is planar as shown in FIGS. 6A and 6B or, alternatively, shaped to mimic a portion of the human anatomy, tissue or organ.


For example, FIG. 7 illustrates a support 52 that is shaped to mimic a human uterus. The support 52 includes a first layer 57 connected to a second layer 55. In one variation, the first layer 57 is made of any suitable polymeric material such as a sheet of elastomeric material and the second layer 55 is made of any suitable polymeric material such as a low-density elastomeric foam. The second layer 55 serves as a support for the first layer 57 and advantageously permits the tumors 38 within the modules 50 or the tumors 38 by themselves to be connected to the support 52 and realistically extend deeply into the support 52 and be dispersed throughout the support 52 in various locations and orientations including being embedded into the first layer 57 as shown in FIG. 7. Tumor or module receiving portions 61 are formed in at least one of the first layer 57 and second layer 55. The tumor receiving portions 61 may be pockets that are preformed in the second layer 55 or can be formed by the user by cutting slits into the second layer 55. In one variation, the tumors 38 are configured to mimic fibroid tumors commonly found in the human uterus. Examples of fibroid tumors that are simulated by the tumors 38 disposed in the support include but are not limited to one or more of the following types of fibroids: pedunculated submucosal fibroids, subserosal fibroids, submucosal fibroids, pedunculated subserosal fibroids and intramural fibroids. The user can approach the support 52 to excise the simulated tumors 38 from the first surface 51 or the second surface 53 via the access channel or opening 63. In one variation, the opening 63 serves as the only opening to the hollow portion 59 or alternatively the support 52 can have a substantially C-shaped planar configuration with access available to the user from above or below the planar C-shaped structure.


In one variation, the module support 52 in any of the variations is not planar but is provided with a landscape that includes curves and other structures, mountains and valleys and various textures. The varying landscape provides the user with various levels of difficulty in approaching each tumor location requiring the user to navigate around artifacts and features that may obscure the tumor location. These structural artifacts in the tumor support 52 may be integrally formed with the tumor support 52 or also be modular in structure similar to the tumor modules 50 making the anatomy landscape modules removable and interchangeable. Tumor modules 50 are interchangeable with non-tumor modules that include, for example, features and artifacts or textures made of silicone or other material extending outwardly or inwardly from the one or more of the upper and lower surfaces 51, 53 of the module support 52. The features in such non-tumor modules can have various shapes to mimic anatomy that includes adjacent organ structures or tissues. For example, a non-tumor module can include a tubular form of silicone to mimic an intestine. The non-tumor and tumor modules 50 are removably connected to the module support 52 by any means known to one skilled in the art enabling the user to discard a module after use and then to continue practicing by replacing the discarded module or moving to an adjacent module 50 in the module support 52 or changing out a tumor module 50 for another tumor module 50 having a different feature or level of difficulty.


A variation of the tumor module 50 is shown in FIGS. 8 and 9. The tumor module 50 includes a simulated tissue portion 60 connected to a support 62. In the variation shown, the support 62 includes a top frame 64 connected to a bottom frame 66. At least one of the top frame 64 and bottom frame 66 includes a window. The top frame 64 having a window 68 is shown in FIG. 8. The bottom frame 66 may or may not include a window. If windows are provided in both the top frame 64 and the bottom frame 66, the windows are aligned at least in part. The support 62 is sized and configured to receive a simulated tissue portion 60 between the top frame 64 and the bottom frame 66. The top frame 64 is connectable to the bottom frame 66 to capture the unitary simulated tissue portion 60 or a simulated tissue portion 60 formed from multiple layers and, in one variation, separable. In one variation, the frames 64, 66 are spaced apart from each other using spacers 70. Furthermore, at least one of the top and bottom frames 64, 66 includes one or more connecting features 72 configured to secure the tumor module 50 to a tumor support 52 (not shown). In FIG. 9, the connecting features 72 are shown as extending pegs for insertion into corresponding holes formed in the tumor support 52 to provide a snap-fit engagement. A friction fit or other fasteners or connecting means such as hook-and-loop type materials can be employed on the module 50 and module support 52 to connect the module 50 to the support 52 in a removable fashion.


Still referencing FIGS. 8 and 9, the simulated tissue portion 60 can be any of the constructs described above with reference to FIGS. 2-5. With windows formed in both the first and second frames 64, 66, the simulated tissue portion 60 can be approached from either side of the module 50. Any layer described above as a cover layer may act as a top layer or as a bottom layer depending on from which side or direction the simulated tissue portion 60 is approached. For example, a base layer may also serve as a top layer or as a bottom layer depending on which side or direction the simulated tissue portion 60 is approached. In such, bi-directional constructs, the thicknesses and colors of the layers may be adjusted accordingly to provide the desired simulated effect.


The simulated tissue portion 60 in FIG. 9 includes a first layer 74 and a second layer 76. The first and second layers 74, 76 are made from a polymeric material configured to mimic real live tissue such as silicone or other polymer and can include dye of any one or more appropriate colors or mesh, fabric, or other reinforcement. Each of the layers 74, 76 includes a tumor receiving portion 78, 80, respectively. Each tumor receiving portion 78, 80 is a concavity, indent, half-pocket or a location of reduced layer thickness that is formed in the layers 74, 76. The tumor receiving portions 78, 80 are substantially aligned to form a pocket for the tumor 38. Although each layer 74, 76 in FIG. 9 is shown with a tumor receiving portion 78, 80, a single tumor receiving portion is formed in at least one of the first and second layers 74, 76 in one variation. A tumor 38 is disposed within the pocket formed by one or more tumor receiving portions 78, 80 formed in the one or more layers 74, 76. The tumor 38 may be adhered to either layer 74, 76 or free floating inside the pocket. As shown in FIG. 9, the tumor receiving portion formed in a layer can be considered to be one type of defect and the variation of FIG. 9 describes a simulated tissue construct comprising two defect layers with a tumor therebetween. As a user approaches the simulated tissue portion 60, the user will see the target tumor location. Visualization of the target tumor 38 is enhanced by the tumor receiving portion being thinner in thickness relative to the rest of the layer with the thinning of the layer being provided by the concavity or pocket. The user will then cut in the general location of the tumor cutting into at least one of the layers 74, 76 to remove the tumor 38. Cutting through one or more layers completes the creation of a gap or full defect which the user can then practice suturing or otherwise closing together. In another variation, there is no tumor receiving portion formed in the layers 74, 76. In such a variation, at least one tumor is disposed between the two layers 74, 76 wherein the layers 74, 76 have a substantially uniform thickness with the tumor 38 creating a minor bulge in the layers.


Turning now to FIGS. 10A, 10B, 11A, 11B and 12, there is shown another variation of a simulated tissue portion 86. The tissue portion 86 can be integral or modular as described above. The tissue portion 86 includes a base layer 88 formed of any suitable polymeric material such as silicone or other elastomeric polymer that may or may not include a reinforcement material such as fabric, mesh, nylon or other reinforcement material or filler that will resist tearing while carrying sutures or while being sutured. The base layer 88 is connected to a defect layer 90 that is overlaid onto the base layer 88. The defect layer 90 includes a plurality of protrusions extending upwardly from the base layer 88. The defect layer 90 may be integrally formed with the base layer 88 or be a separate layer that is adhered to the base layer 88. As can be seen in FIGS. 10A, 11A and 12, the defect layer 90 is configured into a lattice shaped pattern such that the lattice is raised above the base layer 88 or projects upwardly from the base layer 88. A lattice pattern is exemplary and any shape may be formed by the defect layer 90 such that it contains a plurality of adjacent projections. These projections of the base layer 90 provide the user with locations to hook a suture needle into and as a platform to raise the tumor 38a, 38b above the base layer 88 for easy excision. The tumors 38a, 38b may be adhered to the defect layer 90 and a cover layer 92 may be included in one variation. FIGS. 10A and 11A show the base layer 88, defect layer 90, tumors 38a, 38b and a cover layer 92 in a semi-exploded view of the simulated tissue portion 86 wherein the cover layer 92 is raised above the other layers. The tumor 38a of FIG. 10a is substantially planar and is shown covered in FIG. 10B by the cover layer 92. Tumor 38b of FIG. 11A has greater height and is substantially spherical in shape and FIG. 11B shows the spherical tumor 38b covered with the cover layer 92 leaving a raised portion or protuberance in the construct. FIG. 12 shows the tumor 38 being removed leaving a remnant defect 94 in the base layer 88 and a suture needle crossing the gap in the defect 94 with the defect having been accessed under or through the cover layer 92.


While certain embodiments have been particularly shown and described with reference to exemplary embodiments thereof, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope thereof as defined by the following claims.

Claims
  • 1. A modular simulated tissue construct for training surgical excision of tumors, comprising: a module support having a thickness defined by a top surface opposite from a bottom surface, the module support comprising: a first support layer having a first surface and a second surface interconnected by a sidewall defining a first thickness; a first plurality of module-receiving portions being formed in the first support layer; anda second support layer having a first surface and a second surface interconnected by a sidewall defining a second thickness; a second plurality of module-receiving portions being formed in the second support layer; the second support layer being located below and connected to the first support layer such that the first surface of the second support layer contacts the second surface of the first support layer; anda plurality of simulated tumor modules sized and configured to be removably and interchangeably inserted into the first plurality of module-receiving portions and/or the second plurality of module-receiving portions,wherein some of the second plurality of module-receiving portions formed in the second support layer are non-aligned with the first plurality of module-receiving portions formed in the first support layer such that a simulated tumor module selected from the plurality of simulated tumor modules inserted into a non-aligned module-receiving portion of the second plurality of module-receiving portions is buried inside the second support layer; the module support being configured such that at least one of the first support layer and the second support layer is surgically incisable so as to access the simulated tumor module buried inside the second support layer, andwherein a remnant defect created in the first support layer or the second support layer is surgically closable with sutures or staples in the same surgical procedure.
  • 2. The modular simulated tissue construct of claim 1 wherein the top surface and bottom surface of the module support correspond respectively to the first surface of the first support layer and the second surface of the second support layer.
  • 3. The modular simulated tissue construct of claim 1 wherein: each module-receiving portion of the first and second pluralities of module-receiving portions defines a cavity having an opening in their respective first surface that extends into the first support layer and second support layer, respectively, of the module support;some module-receiving portions of the first and second pluralities of module-receiving portions form a bottom wall in their respective first support layer or second support layer; andthe bottom wall is formed at a different depth in the first and second support layers of the module support for each plurality of module-receiving portions.
  • 4. The modular simulated tissue construct of claim 1 wherein some module-receiving portions of the first and second pluralities of module-receiving portions are aligned such that the aligned module-receiving portions comprise a first opening in the top surface extending into the module support through the first and second support layers to interconnect with a second opening in the bottom surface; wherein each simulated tumor module of the plurality of simulated tumor modules is configured to be disposed between the first and second openings or at one of the first or second openings using connecting features.
  • 5. The modular simulated tissue construct of claim 1 wherein the second support layer is configured to provide an extended depth to the module support and to serve as a support for the first support layer.
  • 6. The modular simulated tissue construct of claim 1 wherein some module-receiving portions of the second plurality of module-receiving portions are aligned with the first plurality of module-receiving portions formed in the first support layer.
  • 7. The modular simulated tissue construct of claim 6 wherein at least one module-receiving portion from said some of the second plurality of module-receiving portions has a different shape than a shape of a correspondingly aligned module-receiving portion of the first support layer.
  • 8. The modular simulated tissue construct of claim 1 wherein the first support layer is made of elastomeric polymer and the second support layer is made of low-density elastomeric foam.
  • 9. The modular simulated tissue construct of claim 1 wherein the thickness of the module support is configured such that at least some of the module-receiving portions of the first and second pluralities of module-receiving portions are formed at different depths across the first and second support layers of the module support, providing a construct with varying depths for positioning the plurality of simulated tumor modules.
  • 10. A system comprising: a surgical training device configured to mimic a torso, the surgical training device comprising: a base; anda top cover connected to and spaced apart from the base to define an internal cavity between the top cover and the base; the internal cavity being at least partially obstructed from direct observation by a user; the top cover comprising an opening and an insert sized and configured to fit into the opening of the top cover and connect thereto; andthe modular simulated tissue construct of claim 1, wherein the modular simulated tissue construct is configured for placement inside the internal cavity or suspension and connection to the insert of the top cover.
  • 11. The modular simulated tissue construct of claim 1 wherein a simulated tumor module of the plurality of simulated tumor modules inserted into a module-receiving portion of the module support is surgically accessible from the top surface and the bottom surface of the module support, providing a bi-directional construct.
  • 12. The modular simulated tissue construct of claim 1 wherein at least one of the plurality of simulated tumor modules consists of one or more simulated tumors.
  • 13. The modular simulated tissue construct of claim 1 wherein some of the plurality of simulated tumor modules comprise a simulated tissue portion, the simulated tissue portion comprising at least one simulated tumor and/or at least one other surgical target.
  • 14. The modular simulated tissue construct of claim 13 wherein: the simulated tissue portion comprises a base layer and a defect layer overlaid onto the base layer;the defect layer is located above and connected to the base layer such that a bottom surface of the defect layer contacts a top surface of the base layer, the defect layer having a thickness between a top surface and bottom surface and including at least one defect; andthe at least one defect defines at least one gap having an opening at the top surface of the defect layer.
  • 15. The modular simulated tissue construct of claim 14 wherein the at least one simulated tumor is located above and in contact with the defect layer overlaying at least a portion of the at least one defect and bridging the opening of the at least one gap; and wherein a transparent cover layer is located above the base layer and overlaying the at least one simulated tumor, the at least one simulated tumor being removably located between the cover layer and the defect layer.
  • 16. The modular simulated tissue construct of claim 13 wherein the simulated tissue portion comprises a first elastomeric layer and a second elastomeric layer, at least one of the first and second elastomeric layers being made of silicone and a mesh reinforcement; and wherein: the at least one simulated tumor is made of silicone material and is located between the first elastomeric layer and the second elastomeric layer; the simulated tissue portion is connected to a frame so as to span a frame opening; and the frame has connecting features configured to connect the frame to the module support within each of the first and second plurality of module-receiving portions.
  • 17. The modular simulated tissue construct of claim 16 wherein at least one of the first elastomeric layer and the second elastomeric layer comprises a tumor-receiving portion, the tumor-receiving portion comprising a concavity, indent, half-pocket or a location of reduced thickness formed in the first and second elastomeric layers; and wherein the at least one simulated tumor is located in the tumor-receiving portion.
  • 18. The modular simulated tissue construct of claim 13 wherein: the simulated tissue portion comprises a base layer and a defect layer overlaid onto the base layer; the defect layer comprises a plurality of protrusions extending upwardly from the base layer; the defect layer is configured into a lattice shaped pattern raising above the base layer or projecting upwardly from the base layer; and the defect layer is formed integrally with the base layer or adhered to the base layer as a separate layer.
  • 19. The modular simulated tissue construct of claim 18 wherein: the simulated tissue portion further comprises a cover layer located above the base layer and the defect layer;the at least one simulated tumor is disposed between the defect layer and the cover layer; andthe at least one simulated tumor has a planar or spherical shape, the spherical tumor being configured as a raised portion or protuberance in the simulated tissue portion once covered by the cover layer.
  • 20. The modular simulated tissue construct of claim 1 wherein the module support is shaped to mimic a human uterus or at least in part to simulate a human organ.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 13/656,467 entitled “Simulated tissue structure for surgical training” filed on Oct. 19, 2012 which claims priority to and benefit of U.S. Provisional Patent Application Ser. No. 61/549,838 entitled “Simulated tissue structure for surgical training” filed on Oct. 21, 2011 all of which are incorporated herein by reference in their entireties.

US Referenced Citations (413)
Number Name Date Kind
184573 Becker Nov 1876 A
2127774 Jacobson Aug 1938 A
2284888 Arneil, Jr. Jun 1942 A
2495568 Coel Jan 1950 A
3789518 Chase Feb 1974 A
3921311 Beasley et al. Nov 1975 A
3991490 Markman Nov 1976 A
4001951 Fasse Jan 1977 A
4332569 Burbank Jun 1982 A
4371345 Palmer et al. Feb 1983 A
4459113 Boscaro Gatti et al. Jul 1984 A
4481001 Graham et al. Nov 1984 A
4596528 Lewis et al. Jun 1986 A
4726772 Amplatz Feb 1988 A
4737109 Abramson Apr 1988 A
4789340 Zikria Dec 1988 A
4907973 Hon Mar 1990 A
4938696 Foster et al. Jul 1990 A
5061187 Jerath Oct 1991 A
5083962 Pracas Jan 1992 A
5104328 Lounsbury Apr 1992 A
5149270 McKeown Sep 1992 A
5180308 Garito et al. Jan 1993 A
5230630 Burgett Jul 1993 A
5273435 Jacobson Dec 1993 A
5295694 Levin Mar 1994 A
5318448 Garito et al. Jun 1994 A
5320537 Watson Jun 1994 A
5358408 Medina Oct 1994 A
5368487 Medina Nov 1994 A
5403191 Tuason Apr 1995 A
5416129 Chaudhary May 1995 A
5425644 Szinicz Jun 1995 A
5425731 Daniel et al. Jun 1995 A
5472345 Eggert Dec 1995 A
5518406 Waters May 1996 A
5518407 Greenfield et al. May 1996 A
5520633 Costin May 1996 A
5620326 Younker Apr 1997 A
5720742 Zacharias Feb 1998 A
5722836 Younker Mar 1998 A
5727948 Jordan Mar 1998 A
5762458 Wang et al. Jun 1998 A
5769640 Jacobus et al. Jun 1998 A
5775916 Cooper et al. Jul 1998 A
5785531 Leung Jul 1998 A
5800178 Gillio Sep 1998 A
5803746 Barrie et al. Sep 1998 A
5807378 Jensen et al. Sep 1998 A
5810880 Jensen et al. Sep 1998 A
5814038 Jensen et al. Sep 1998 A
5850033 Mirzeabasov et al. Dec 1998 A
5855583 Wang et al. Jan 1999 A
5873732 Hasson Feb 1999 A
5873863 Komlosi Feb 1999 A
5908302 Goldfarb Jun 1999 A
5947743 Hasson Sep 1999 A
5951301 Younker Sep 1999 A
6080181 Jensen et al. Jun 2000 A
6083008 Yamada et al. Jul 2000 A
6113395 Hon Sep 2000 A
6234804 Yong May 2001 B1
6271278 Park et al. Aug 2001 B1
6336812 Cooper et al. Jan 2002 B1
6398557 Hoballah Jun 2002 B1
6413264 Jensen et al. Jul 2002 B1
6474993 Grund et al. Nov 2002 B1
6485308 Goldstein Nov 2002 B1
6488507 Stoloff et al. Dec 2002 B1
6511325 Lalka et al. Jan 2003 B1
6517354 Levy Feb 2003 B1
6568941 Goldstein May 2003 B1
6589057 Keenan et al. Jul 2003 B1
6620174 Jensen et al. Sep 2003 B2
6654000 Rosenberg Nov 2003 B2
6659776 Aumann et al. Dec 2003 B1
6773263 Nicholls et al. Aug 2004 B2
6780016 Toly Aug 2004 B1
6817973 Merril et al. Nov 2004 B2
6820025 Bachmann et al. Nov 2004 B2
6857878 Chosack et al. Feb 2005 B1
6863536 Fisher et al. Mar 2005 B1
6866514 Von Roeschlaub et al. Mar 2005 B2
6887082 Shun May 2005 B2
6929481 Alexander et al. Aug 2005 B1
6939138 Chosack et al. Sep 2005 B2
6950025 Nguyen Sep 2005 B1
6997719 Wellman et al. Feb 2006 B2
7008232 Brassel Mar 2006 B2
7025064 Wang et al. Apr 2006 B2
7056123 Gregorio et al. Jun 2006 B2
7080984 Cohen Jul 2006 B1
7118582 Wang et al. Oct 2006 B1
7255565 Keegan Aug 2007 B2
7269532 David et al. Sep 2007 B2
7272766 Sakezles Sep 2007 B2
7300450 Vleugels et al. Nov 2007 B2
7364582 Lee Apr 2008 B2
7404716 Gregorio et al. Jul 2008 B2
7419376 Sarvazyan et al. Sep 2008 B2
7427199 Sakezles Sep 2008 B2
7431189 Shelton, IV et al. Oct 2008 B2
7441684 Shelton, IV et al. Oct 2008 B2
7465168 Allen et al. Dec 2008 B2
7467075 Humphries et al. Dec 2008 B2
7544062 Hauschild et al. Jun 2009 B1
7549866 Cohen et al. Jun 2009 B2
7553159 Arnal et al. Jun 2009 B1
7575434 Palakodeti Aug 2009 B2
7594815 Toly Sep 2009 B2
7648367 Makower et al. Jan 2010 B1
7648513 Green et al. Jan 2010 B2
7651332 Dupuis et al. Jan 2010 B2
7677897 Sakezles Mar 2010 B2
7775916 Mahoney Aug 2010 B1
7780451 Willobee et al. Aug 2010 B2
7802990 Korndorffer et al. Sep 2010 B2
7803151 Whitman Sep 2010 B2
7806696 Alexander et al. Oct 2010 B2
7819799 Merril et al. Oct 2010 B2
7833018 Alexander et al. Nov 2010 B2
7837473 Koh Nov 2010 B2
7850454 Toly Dec 2010 B2
7850456 Chosack et al. Dec 2010 B2
7854612 Frassica et al. Dec 2010 B2
7857626 Toly Dec 2010 B2
7866983 Hemphill et al. Jan 2011 B2
7931470 Alexander et al. Apr 2011 B2
7931471 Senagore et al. Apr 2011 B2
7993140 Sakezles Aug 2011 B2
8007281 Toly Aug 2011 B2
8007282 Gregorio et al. Aug 2011 B2
8016818 Ellis et al. Sep 2011 B2
8017107 Thomas et al. Sep 2011 B2
8048088 Green et al. Nov 2011 B2
8083691 Goldenberg et al. Dec 2011 B2
8116847 Gattani et al. Feb 2012 B2
8157145 Shelton, IV et al. Apr 2012 B2
8197464 Krever et al. Jun 2012 B2
8205779 Ma et al. Jun 2012 B2
8221129 Parry et al. Jul 2012 B2
8297982 Park et al. Oct 2012 B2
8308817 Egilsson et al. Nov 2012 B2
8323028 Matanhelia Dec 2012 B2
8323029 Toly Dec 2012 B2
8328560 Niblock et al. Dec 2012 B2
8342851 Speeg et al. Jan 2013 B1
8403674 Feygin et al. Mar 2013 B2
8403675 Stoianovici et al. Mar 2013 B2
8403676 Frassica et al. Mar 2013 B2
8439687 Morriss et al. May 2013 B1
8442621 Gorek et al. May 2013 B2
8454368 Ault et al. Jun 2013 B2
8459094 Yanni Jun 2013 B2
8459520 Giordano et al. Jun 2013 B2
8460002 Wang et al. Jun 2013 B2
8465771 Wan et al. Jun 2013 B2
8469716 Fedotov et al. Jun 2013 B2
8480407 Campbell et al. Jul 2013 B2
8480408 Ishii et al. Jul 2013 B2
8491309 Parry et al. Jul 2013 B2
8500753 Green et al. Aug 2013 B2
8517243 Giordano et al. Aug 2013 B2
8521252 Diez Aug 2013 B2
8544711 Ma et al. Oct 2013 B2
8556635 Toly Oct 2013 B2
8613621 Henderickson et al. Dec 2013 B2
D699297 Bahsooun et al. Feb 2014 S
8641423 Gumkowski Feb 2014 B2
8647125 Johns et al. Feb 2014 B2
8708213 Shelton, IV et al. Apr 2014 B2
8708707 Hendrickson et al. Apr 2014 B2
8764452 Pravong et al. Jul 2014 B2
8800839 Beetel Aug 2014 B2
8801438 Sakezles Aug 2014 B2
8807414 Ross et al. Aug 2014 B2
8808311 Heinrich et al. Aug 2014 B2
8827988 Belson et al. Sep 2014 B2
8840628 Green et al. Sep 2014 B2
8870576 Millon et al. Oct 2014 B2
8893946 Boudreaux et al. Nov 2014 B2
8911238 Forsythe Dec 2014 B2
8915742 Hendrickson et al. Dec 2014 B2
8945095 Blumenkranz et al. Feb 2015 B2
8961190 Hart et al. Feb 2015 B2
8966954 Ni et al. Mar 2015 B2
8968003 Hendrickson et al. Mar 2015 B2
9008989 Wilson et al. Apr 2015 B2
9026247 White May 2015 B2
9050201 Egilsson et al. Jun 2015 B2
9096744 Wan et al. Aug 2015 B2
9117377 Shim et al. Aug 2015 B2
9119572 Gorek et al. Sep 2015 B2
9123261 Lowe Sep 2015 B2
9129054 Nawana et al. Sep 2015 B2
9196176 Hager et al. Nov 2015 B2
9226799 Lightcap et al. Jan 2016 B2
9257055 Endo et al. Feb 2016 B2
9265587 Vancamberg et al. Feb 2016 B2
9295468 Heinrich et al. Mar 2016 B2
9351714 Ross et al. May 2016 B2
9336694 Shim et al. Jun 2016 B2
9358682 Ruiz Morales Jun 2016 B2
9364224 Nicholas et al. Jun 2016 B2
9364279 Houser et al. Jun 2016 B2
9370361 Viola et al. Jun 2016 B2
9373270 Miyazaki Jun 2016 B2
9387276 Sun et al. Jul 2016 B2
9427496 Sun et al. Aug 2016 B2
9439649 Shelton, IV et al. Sep 2016 B2
9439733 Ha et al. Sep 2016 B2
9449532 Black et al. Sep 2016 B2
9468438 Baber et al. Oct 2016 B2
20010019818 Yong Sep 2001 A1
20030031993 Pugh Feb 2003 A1
20030091967 Chosack et al. May 2003 A1
20030176770 Merril et al. Sep 2003 A1
20040005423 Dalton et al. Jan 2004 A1
20040126746 Toly Jul 2004 A1
20040248072 Gray et al. Dec 2004 A1
20050008997 Herman Jan 2005 A1
20050026125 Toly Feb 2005 A1
20050064378 Toly Mar 2005 A1
20050084833 Lacey et al. Apr 2005 A1
20050131390 Heinrich et al. Jun 2005 A1
20050142525 Cotin et al. Jun 2005 A1
20050192595 Green et al. Sep 2005 A1
20050196739 Moriyama Sep 2005 A1
20050196740 Moriyana Sep 2005 A1
20050214727 Stoianovici et al. Sep 2005 A1
20060046235 Alexander et al. Feb 2006 A1
20060252019 Burkitt et al. Nov 2006 A1
20060275741 Chewning et al. Dec 2006 A1
20070074584 Talarico et al. Apr 2007 A1
20070078484 Talarico et al. Apr 2007 A1
20070148626 Ikeda Jun 2007 A1
20070166682 Yarin et al. Jul 2007 A1
20070197895 Nycz et al. Aug 2007 A1
20070225734 Bell et al. Sep 2007 A1
20070275359 Rotnes et al. Nov 2007 A1
20080032272 Palakodeti Feb 2008 A1
20080032273 Macnamara et al. Feb 2008 A1
20080052034 David et al. Feb 2008 A1
20080064017 Grundmeyer, III Mar 2008 A1
20080097501 Blier Apr 2008 A1
20080108869 Sanders et al. May 2008 A1
20080187895 Sakezles Aug 2008 A1
20080188948 Flatt Aug 2008 A1
20080299529 Schaller Dec 2008 A1
20080317818 Griffith et al. Dec 2008 A1
20090246747 Buckman, Jr. Jan 2009 A1
20090068627 Toly Mar 2009 A1
20090142739 Wang et al. Jun 2009 A1
20090142741 Ault et al. Jun 2009 A1
20090143642 Takahashi et al. Jun 2009 A1
20090176196 Niblock et al. Jul 2009 A1
20090187079 Albrecht et al. Jul 2009 A1
20090298034 Parry et al. Dec 2009 A1
20090314550 Layton Dec 2009 A1
20100094312 Ruiz Morales et al. Apr 2010 A1
20100099067 Agro Apr 2010 A1
20100167248 Ryan Jul 2010 A1
20100167249 Ryan Jul 2010 A1
20100167250 Ryan et al. Jul 2010 A1
20100167253 Ryan et al. Jul 2010 A1
20100167254 Nguyen Jul 2010 A1
20100204713 Ruiz Morales Aug 2010 A1
20100209899 Park Aug 2010 A1
20100248200 Ladak Sep 2010 A1
20100258611 Smith et al. Oct 2010 A1
20100273136 Kandasami et al. Oct 2010 A1
20100279263 Duryea Nov 2010 A1
20100285094 Gupta Nov 2010 A1
20100324541 Whitman Dec 2010 A1
20110020779 Hannaford et al. Jan 2011 A1
20110046637 Patel et al. Feb 2011 A1
20110046659 Ramstein et al. Feb 2011 A1
20110087238 Wang et al. Apr 2011 A1
20110091855 Miyazaki Apr 2011 A1
20110137337 van den Dool et al. Jun 2011 A1
20110200976 Hou et al. Aug 2011 A1
20110207104 Trotta Aug 2011 A1
20110218550 Ma Sep 2011 A1
20110269109 Miyazaki Nov 2011 A2
20110281251 Mousques Nov 2011 A1
20110301620 Di Betta et al. Dec 2011 A1
20120015337 Hendrickson et al. Jan 2012 A1
20120015339 Hendrickson et al. Jan 2012 A1
20120016362 Heinrich et al. Jan 2012 A1
20120028231 Misawa et al. Feb 2012 A1
20120045743 Misawa et al. Feb 2012 A1
20120065632 Shadduck Mar 2012 A1
20120082970 Pravong Apr 2012 A1
20120115117 Marshall May 2012 A1
20120115118 Marshall May 2012 A1
20120116391 Houser et al. May 2012 A1
20120148994 Hori et al. Jun 2012 A1
20120164616 Endo et al. Jun 2012 A1
20120165866 Kaiser et al. Jun 2012 A1
20120172873 Artale et al. Jul 2012 A1
20120179072 Kegreiss Jul 2012 A1
20120202180 Stock et al. Aug 2012 A1
20120264096 Taylor et al. Oct 2012 A1
20120264097 Newcott et al. Oct 2012 A1
20120282583 Thaler et al. Nov 2012 A1
20120282584 Millon et al. Nov 2012 A1
20120283707 Giordano et al. Nov 2012 A1
20120308977 Tortola Dec 2012 A1
20130087597 Shelton, IV et al. Apr 2013 A1
20130101973 Hoke et al. Apr 2013 A1
20130105552 Weir et al. May 2013 A1
20130116668 Shelton, IV et al. May 2013 A1
20130157240 Hart et al. Jun 2013 A1
20130171288 Harders Jul 2013 A1
20130177890 Sakezles Jul 2013 A1
20130218166 Elmore Aug 2013 A1
20130224709 Riojas et al. Aug 2013 A1
20130245681 Straehnz et al. Sep 2013 A1
20130253480 Kimball et al. Sep 2013 A1
20130267876 Leckenby et al. Oct 2013 A1
20130282038 Dannaher et al. Oct 2013 A1
20130302771 Alderete Nov 2013 A1
20130324991 Clem et al. Dec 2013 A1
20130324999 Price et al. Dec 2013 A1
20140011172 Lowe Jan 2014 A1
20140017651 Sugimoto et al. Jan 2014 A1
20140030682 Thilenius Jan 2014 A1
20140038151 Hart Feb 2014 A1
20140051049 Jarc et al. Feb 2014 A1
20140072941 Hendrickson et al. Mar 2014 A1
20140087345 Breslin et al. Mar 2014 A1
20140087346 Breslin et al. Mar 2014 A1
20140087347 Tracy et al. Mar 2014 A1
20140087348 Tracy et al. Mar 2014 A1
20140088413 Von Bucsh et al. Mar 2014 A1
20140093852 Poulsen et al. Apr 2014 A1
20140093854 Poulsen et al. Apr 2014 A1
20140106328 Loor Apr 2014 A1
20140107471 Haider et al. Apr 2014 A1
20140170623 Jarstad et al. Jun 2014 A1
20140186809 Hendrickson et al. Jul 2014 A1
20140187855 Nagale et al. Jul 2014 A1
20140200561 Ingmanson et al. Jul 2014 A1
20140220530 Merkle et al. Aug 2014 A1
20140242564 Pravong et al. Aug 2014 A1
20140246479 Baber et al. Sep 2014 A1
20140248596 Hart et al. Sep 2014 A1
20140263538 Leimbach et al. Sep 2014 A1
20140272878 Shim et al. Sep 2014 A1
20140272879 Shim et al. Sep 2014 A1
20140275795 Little et al. Sep 2014 A1
20140275981 Selover et al. Sep 2014 A1
20140277017 Leimbach et al. Sep 2014 A1
20140303643 Ha et al. Oct 2014 A1
20140303646 Morgan et al. Oct 2014 A1
20140303660 Boyden et al. Oct 2014 A1
20140342334 Black et al. Nov 2014 A1
20140349266 Choi Nov 2014 A1
20140350530 Ross et al. Nov 2014 A1
20140357977 Zhou Dec 2014 A1
20140370477 Black et al. Dec 2014 A1
20140371761 Juanpera Dec 2014 A1
20140378995 Kumar et al. Dec 2014 A1
20150076207 Boudreaux et al. Mar 2015 A1
20150132732 Hart et al. May 2015 A1
20150135832 Blumenkranz et al. May 2015 A1
20150148660 Weiss et al. May 2015 A1
20150164598 Blumenkranz et al. Jun 2015 A1
20150209035 Zemlock Jul 2015 A1
20150209059 Trees et al. Jul 2015 A1
20150209573 Hibner et al. Jul 2015 A1
20150228206 Shim et al. Aug 2015 A1
20150262511 Lin et al. Sep 2015 A1
20150265431 Egilsson et al. Sep 2015 A1
20150272571 Leimbach et al. Oct 2015 A1
20150272574 Leimbach et al. Oct 2015 A1
20150272580 Leimbach et al. Oct 2015 A1
20150272581 Leimbach et al. Oct 2015 A1
20150272583 Leimbach et al. Oct 2015 A1
20150272604 Chowaniec et al. Oct 2015 A1
20150332609 Alexander Nov 2015 A1
20150358426 Kimball et al. Dec 2015 A1
20150371560 Lowe Dec 2015 A1
20150374378 Giordano et al. Dec 2015 A1
20150374449 Chowaniec et al. Dec 2015 A1
20160000437 Giordano et al. Jan 2016 A1
20160022374 Haider et al. Jan 2016 A1
20160030240 Gonenc et al. Feb 2016 A1
20160031091 Popovic et al. Feb 2016 A1
20160058534 Derwin et al. Mar 2016 A1
20160066909 Baber et al. Mar 2016 A1
20160070436 Thomas et al. Mar 2016 A1
20160073928 Soper et al. Mar 2016 A1
20160074103 Sartor Mar 2016 A1
20160098933 Reiley et al. Apr 2016 A1
20160104394 Miyazaki Apr 2016 A1
20160117956 Larsson et al. Apr 2016 A1
20160125762 Becker et al. May 2016 A1
20160133158 Sui et al. May 2016 A1
20160140876 Jabbour et al. May 2016 A1
20160194378 Cass et al. Jul 2016 A1
20160199059 Shelton, IV et al. Jul 2016 A1
20160220150 Sharonov Aug 2016 A1
20160220314 Huelman et al. Aug 2016 A1
20160225288 East et al. Aug 2016 A1
20160232819 Hofstetter et al. Aug 2016 A1
20160235494 Shelton, IV et al. Sep 2016 A1
20160256187 Shelton, IV et al. Sep 2016 A1
20160256229 Morgan et al. Sep 2016 A1
20160262736 Ross et al. Sep 2016 A1
20160262745 Morgan et al. Sep 2016 A1
20160293055 Hofstetter Oct 2016 A1
20160296144 Gaddam et al. Oct 2016 A1
Foreign Referenced Citations (84)
Number Date Country
2 293 585 Dec 1998 CA
2421706 Feb 2001 CN
2751372 Jan 2006 CN
2909427 Jun 2007 CN
101313842 Dec 2008 CN
101528780 Sep 2009 CN
201364679 Dec 2009 CN
201955979 Aug 2011 CN
102458496 May 2012 CN
202443680 Sep 2012 CN
202563792 Nov 2012 CN
202601055 Dec 2012 CN
202694651 Jan 2013 CN
103050040 Apr 2013 CN
203013103 Jun 2013 CN
203038549 Jul 2013 CN
203338651 Dec 2013 CN
203397593 Jan 2014 CN
203562128 Apr 2014 CN
102596275 Jun 2014 CN
103845757 Jun 2014 CN
103886797 Jun 2014 CN
103396562 Jul 2015 CN
105194740 Dec 2015 CN
105504166 Apr 2016 CN
9102218 May 1991 DE
41 05 892 Aug 1992 DE
44 14 832 Nov 1995 DE
19716341 Sep 2000 DE
1 024 173 Aug 2000 EP
1 609 431 Dec 2005 EP
2 068 295 Jun 2009 EP
2 218 570 Aug 2010 EP
2 691 826 Dec 1993 FR
2 917 876 Dec 2008 FR
2 917 876 Dec 2008 FR
2488994 Sep 2012 GB
10 211160 Aug 1998 JP
2001005378 Jan 2001 JP
2006187566 Jul 2006 JP
2009063787 Mar 2009 JP
2009236963 Oct 2009 JP
3162161 Aug 2010 JP
2011113056 Jun 2011 JP
2013127496 Jun 2013 JP
101231565 Feb 2013 KR
106230 Sep 2013 PT
WO 199406109 Mar 1994 WO
WO 1996042076 Dec 1996 WO
WO 199858358 Dec 1998 WO
WO 199901074 Jan 1999 WO
WO 200036577 Jun 2000 WO
WO200238039 May 2002 WO
WO 200238039 Jun 2002 WO
WO 2004032095 Apr 2004 WO
WO 2004082486 Sep 2004 WO
WO 2005071639 Aug 2005 WO
WO 2005083653 Sep 2005 WO
WO 2006083963 Aug 2006 WO
WO 2007068360 Jun 2007 WO
WO 2008021720 Feb 2008 WO
WO 2008103383 Aug 2008 WO
WO 2009000939 Dec 2008 WO
WO 2009089614 Jul 2009 WO
WO 2010094730 Aug 2010 WO
WO 2011035410 Mar 2011 WO
WO 2011046606 Apr 2011 WO
WO 2011127379 Oct 2011 WO
WO 2011151304 Dec 2011 WO
WO 2012149606 Nov 2012 WO
WO 2012168287 Dec 2012 WO
WO 2012175993 Dec 2012 WO
WO 2013048978 Apr 2013 WO
WO 2013103956 Jul 2013 WO
WO 2014022815 Feb 2014 WO
WO 2014093669 Jun 2014 WO
WO 2014197793 Dec 2014 WO
WO 2015148817 Oct 2015 WO
WO 2016138528 Sep 2016 WO
WO 2016183412 Nov 2016 WO
WO 2016198238 Dec 2016 WO
WO 2016201085 Dec 2016 WO
WO 2017031214 Feb 2017 WO
WO 2017042301 Mar 2017 WO
Non-Patent Literature Citations (85)
Entry
Society of Laparoendoscopic Surgeons, “Future Technology Innovation in Surgery, Space, and Business” http://www.laparoscopytoday.com/endourology/page/2/ , Figure 1B: http://laparoscopy.blogs.com/laparoscopy_today/images/6-1/6-1VlaovicPicB.jpg , Sep. 5-8, 2007, 10 pgs.
Miyazaki Enterprises, “Miya Model Pelvic Surgery Training Model and Video,” www.miyazakienterprises, printed Jul. 1, 2016, 1 pg.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2015/059668 titled “Simulated Tissue Models and Methods” dated Apr. 26, 2016, 20 pgs.
Australian Patent Office, Patent Examination Report No. 1 for Australian Application No. 2012358851 titled “Advanced Surgical Simulation” dated May 26, 2016, 3 pgs.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2016/032292 titled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated Jul. 14, 2016, 11 pgs.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2016/018697 titled “Simulated Tissue Structures and Methods,” dated Jul. 14, 2016, 21 pgs.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2016/034591 titled “Surgical Training Model for Laparoscopic Procedures,” dated Aug. 8, 2016, 18 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/036664 titled “Hysterectomy Model”, dated Aug. 19, 2016, 15 pgs.
3D-MED Corporation, “Validated Training Course for Laparoscopic Skills”, https://www.3-dmed.com/sites/default/files/product-additional/product-spec/Validated%20Training%20Course%20for%for%20Laparoscopic%20Skills.docx_3.pdf , printed Aug. 23, 2016, pp. 1-6.
3D-MED Corporation, “Loops and Wire #1” https://www.3-dmed.com/product/loops-and-wire-1 , printed Aug. 23, 2016, 4 pgs.
Barrier, et al., “A Novel and Inexpensive Vaginal Hysterectomy Simulatory,” Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare, vol. 7, No. 6, Dec. 1, 2012, pp. 374-379.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/018697, entitled “Simulated Tissue Structures and Methods,” dated Aug. 31, 2017, 14 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/062363, dated Jan. 22, 2014, entitled “Surgical Training Model for Laparoscopic Procedures.”
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/061949, dated Feb. 17, 2014, entitled “Surgical Training Model for Laparoscopic Procedures.”
Anonymous: Realsim Systems—LTS2000, Sep. 4, 2005, pp. 1-2, XP055096193, Retrieved from the Internet: URL:https://web.archive.org/web/2005090403; 3030/http://www.realsimsystems.com/exersizes.htm (retrieved on Jan. 14, 2014).
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/062269, dated Feb. 17, 2014, entitled “Surgical Training Model for Transluminal Procedures.”
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2013/061728 dated Oct. 18, 2013, entitled “Surgical Training Model for Laparoscopic Procedures.”
Limps and Things, EP Guildford MATTU Hernia Trainer, http://limbsandthings.com/us/products/tep-guildford-mattu-hernia-trainer/.
Simulab, Hernia Model, http://www.simulab.com/product/surgery/open/hernia model.
McGill Laparoscopic Inguinal Hernia Simulator, Novel Low-Cost Simulator for Laparoscopic Inguinal Hernia Repair.
University of Wisconsin-Madison Biomedical Engineering, Inguinal Hernia Model, http://bmedesign.engr.wisc.edu/projects/s10/hernia_model/.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2014/038195 titled “Hernia Model”, dated Oct. 15, 2014.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2014/048027 titled “First Entry Model”, dated Oct. 17, 2014.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2014/019840 dated Jul. 4, 2014 entitled “Advanced Surgical Simulation Constructions and Methods.”
Kurashima Y et al, “A tool for training and evaluation of Laparoscopic inguinal hernia repair; the Global Operative Assessment of Laparoscopic Skills-Groin Hernia” American Journal of Surgery, Paul Hoeber, New York, NY, US vol. 201, No. 1, Jan. 1, 2011, pp. 54-61 XP027558745.
European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2013/053497 titled “Simulated Stapling and Energy Based Ligation for Surgical Training” dated Nov. 5, 2013.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2014/042998, title; Gallbladder Model, dated Jan. 7, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability, for PCT application No. PCT/US2013/053497, titled, Simulated Stapling and Energy Based Ligation for Surgical Training, dated Feb. 12, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/062363, titled Surgical Training Model for Laparoscopic Procedures, dated Apr. 9, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/062269, titled Surgical Training Model for Laparoscopic Procedures, dated Apr. 9, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/061557, titled Surgical Training Model for Laparoscopic Procedures, dated Apr. 9, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/061728, titled Surgical Training Model for Laparoscopic Procedures, dated Apr. 9, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2013/061949, titled Surgical Training Model for Laparoscopic Procedures, dated Apr. 9, 2015.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2015/020574, titled “Advanced First Entry Model for Surgical Simulation,” dated Jun. 1, 2015.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2015/022774, dated Jun. 11, 2015 entitled “Simulated Dissectible Tissue.”
Anonymous: Silicone rubber—from Wikipedia, the free encyclopedia, pp. 1-6, XP055192375, Retrieved from the Internet: URL:http://en.wikipedia.org/w.index.php?title=Silicone_rubber&oldid=596456058 (retrieved on May 29, 2015).
Lamouche, et al., “Review of tissue simulating phantoms with controllable optical, mechanical and structural properties for use in optical coherence tomography,” Biomedical Optics Express, Jun. 1, 2012, 18 pgs., vol. 3, No. 6.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2014/038195, titled Hernia Model, dated Nov. 26, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2014/042998, titled “Gallbladder Model” dated Dec. 30, 2015.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2014/048027, titled “First Entry Model” dated Feb. 4, 2016.
European Patent Office, International Search Report for International Application No. PCT/US2011/053859, dated May 4, 2012, entitled “Portable Laparoscopic Trainer”.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2012/60997, dated Mar. 7, 2013, entitled “Simulated Tissue Structure for Surgical Training”.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2012/070971, dated Mar. 18, 2013, entitled “Advanced Surgical Simulation”.
Human Patient Simulator, Medical Education Technologies, Inc., http://www.meti.com (1999) all.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2011/053859, titled “Portable Laparoscopic Trainer” dated Apr. 2, 2013.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2012/070971, dated Jul. 4, 2014, entitled “Advanced Surgical Simulation Constructions and Methods”.
International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2012/070971, titled “Advanced Surgical Simulation” dated Jul. 3 , 2014.
International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2012/060997, titled “Simulated Tissue Structure for Surgical Training” dated Apr. 22, 2014.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/020574, entitled “Advanced First Entry Model for Surgical Simulation,” dated Sep. 22, 2016, 9 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/0043277 titled “Appendectomy Model”, dated Oct. 4, 2016, 12 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/022774, titled “Simulated Dissectible Tissue,” dated Oct. 6, 2016, 9 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/041852 titled “Simulated Dissectible Tissue”, dated Oct. 13, 2016, 12 pgs.
European Patent Office, Examination Report for European Application No. 14733949.3 titled “Gallbladder Model,” dated Dec. 21, 2016, 6 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/062669 titled “Simulated Dissectible Tissue,” dated Apr. 5, 2017, 19 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2017/020389 titled “Simulated Tissue Cartridge”, dated May 24, 2017, 13 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability and Written Opinion for International Application No. PCT/US2015/059668, entitled “Simulated Tissue Models and Methods,” dated May 26, 2017, 16 pgs.
European Patent Office, Invitation to Pay Additional Fees for International Application No. PCT/US2016/062669, titled “Simulated Dissectible Tissue”, dated Feb. 10, 2017, 8 pgs.
European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/055148 titled “Hysterectomy Model”, dated Feb. 28, 2017, 12 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/036664, entitled “Hysterectomy Model,” dated Dec. 21, 2017, 10 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/041852, entitled “Simulated Dissectible Tissue,” dated Jan. 25, 2018, 12 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 17202365.7, titled “Gallbladder Model”, dated Jan. 31, 2018, 8 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/043277, entitled “Appendectomy Model,” dated Feb. 1, 2018, 9 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/0032292, entitled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated Nov. 23, 2017, 2017, 8 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/034591, entitled “Surgical Training Model for Laparoscopic Procedures,” dated Dec. 7, 2017, 2017, 14 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18177751.7, titled “Portable Laparoscopic Trainer,” dated Jul. 13, 2018, 8 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2018/034705, entitled “Laparoscopic Training System,” dated Aug. 20, 2018, 14 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2017/020389, entitled “Simulated Tissue Cartridge,” dated Sep. 13, 2018, 8 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18184147.9, titled “First Entry Model,” dated Nov. 7, 2018, 7 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2017/039113, entitled “Simulated Abdominal Wall,” dated Aug. 7, 2017, 13 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2018/018895, entitled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated May 17, 2018, 12 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/062669, entitled “Simulated Dissectible Tissue,” dated May 31, 2018, 11 pgs.
European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2018/018036, entitled “Laparoscopic Training System,” dated Jun. 8, 2018, 13 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2017/039113, entitled “Simulated Abdominal Wall,” dated Jan. 10, 2019, 8 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18210006.5, titled “Surgical Training Model for Laparoscopic Procedures,” dated Jan. 21, 2019, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18207214.0, titled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated Mar. 28, 2019, 6 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18216002.8, titled “Surgical Training Model for Laparoscopic Procedures,” dated Apr. 2, 2019, 6 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18216005.1, titled “Surgical Training Model for Laparoscopic Procedures,” dated Apr. 2, 2019, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 19159065.2, titled “Simulated Tissue Structures and Methods,” dated May 29, 2019, 8 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2018/018036, entitled “Laparoscopic Training System,” dated Aug. 29, 2019, 8 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2018/018895, entitled “Synthetic Tissue Structures for Electrosurgical Training and Simulation,” dated Sep. 6, 2019, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 20153338.7, titled “Advanced Surgical Simulation Constructions and Methods,” dated Mar. 5, 2020, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 19215545.5, titled “Advanced First Entry Model for Surgical Simulation,” dated Mar. 26, 2020, 8 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 20158500.7, titled “Surgical Training Device,” dated May 14, 2020, 9 pgs.
“Surgical Female Pelvic Trainer (SFPT) with Advanced Surgical Uterus,” Limbs & Things Limited, Issue 1, Jul. 31, 2003, URL:https://www.accuratesolutions.it/wp-content/uploads/2012/08/Surgical_Female_Pelvic_ Trainer_SFPT _with_Advanced_Uterus_Us er_Guide.pdf, retrieved Feb. 21, 2020, 2 pgs.
The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2016/055148, entitled “Hysterectomy Model,” dated Apr. 12, 2018, 12 pgs.
Related Publications (1)
Number Date Country
20160071437 A1 Mar 2016 US
Provisional Applications (1)
Number Date Country
61549838 Oct 2011 US
Continuations (1)
Number Date Country
Parent 13656467 Oct 2012 US
Child 14940444 US